Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(75%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 4 finished

Non-Completion Rate

100.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(4)

Detailed Status

Terminated3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

terminated375%
withdrawn125%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnnot_applicable

REPRISE China - Clinical Evaluation in China

NCT03084510
terminatednot_applicable

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

NCT03618095
terminatednot_applicable

Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement

NCT02202434
terminatednot_applicable

REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System

NCT02854319

Clinical Trials (4)

Showing 4 of 4 trials
NCT03084510Not Applicable

REPRISE China - Clinical Evaluation in China

Withdrawn
NCT03618095Not Applicable

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Terminated
NCT02202434Not Applicable

Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement

Terminated
NCT02854319Not Applicable

REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4